skip to Main Content
TES Pharma | Drug Discovery Innovation

Our Target Discovery Research Strategy

Our agile team based approach guided by combined modern genetic and molecular biology techniques coupled with medicinal, computational and analytical chemistry expertise allows us to rapidly validate and pursue the extensive profiling of novel chemical probes for across different target classes, including nuclear receptors, enzymes, protein-protein interactions, and G-coupled protein receptors.

Our target discovery research strategy provides the basis for delivering First in Class Preclinical Candidates that unlock the potential of Novel Therapeutic Targets.

Internal innovation at TES Pharma is combined with that of key collaborators at world centres of disease excellence to ensure that our projects are pursued with a broad and in-depth understanding of the chemistry and biology necessary to develop novel efficacious treatments for unmet medical need.

Fat cells and capillaries | TES Pharma
Back To Top